Singapore-Based ImmunoScape Secures Licensing Deal for Next-Gen Cancer Therapy
Singapore: ImmunoScape Pte. Ltd., an A*STAR spin-out company supported by Amgen Ventures and EDBi, has announced a groundbreaking exclusive in-licensing agreement with Cue Biopharma Inc. (Nasdaq: CUE). This strategic move aims to spearhead the develop…